Silence of MiR-32-5p Promotes Endothelial Cell Viability by Targeting KLF2 and Serves As a Diagnostic Biomarker of Acute Myocardial Infarction

Overview

Journal Diagn Pathol

Publisher Biomed Central

Specialty Pathology

Date 2020 Mar 5

PMID 32127011

Citations 17

Authors

Yunxiang Dai

Tingguo Yan

Yuming Gao

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNAs (miRNAs) have been investigated in various cardiovascular diseases. As a fatal disease, acute myocardial infarction (AMI) is a serious global health burden. The purpose of this study was to investigate the role of miR-32-5p in AMI patients and human umbilical vein endothelial cells (HUVECs) to explore novel diagnostic and therapeutic approaches for AMI.

Methods: A target prediction tool miRanda and the luciferase activity assay were used to confirm the interaction of miR-32-5p with Kruppel-like factor 2 (KLF2). Effect of miR-32-5p on HUVECs viability was examined using CCK-8 assay. Serum miR-32-5p expression was measured using quantitative Real-Time PCR, and its correlation with myocardial damage and endothelial injury markers and pro-inflammatory cytokines was assessed. Receiver operating characteristic (ROC) curves were used to evaluate the diagnostic value of miR-32-5p in AMI patients.

Results: miR-32-5p, as a direct regulator of KLF2, could suppress the cell proliferation of HUVECs. Serum miR-32-5p expression was elevated in AMI patients and positively correlated with the biomarker levels of myocardial damage and endothelial injury and pro-inflammatory cytokines. The area under the ROC curve for miR-32-5p was 0.949, indicating the relatively high diagnostic accuracy of miR-32-5p in AMI patients.

Conclusion: The data of this study revealed that the increased serum miR-32-5p expression serves as a candidate diagnostic biomarker of AMI, and that miR-32-5p may be involved in the myocardial damage, endothelial injury and inflammatory responses of AMI by targeting KLF2, indicating the potential of miR-32-5p as a diagnostic biomarker and molecular target to improve the treatment of AMI.

Citing Articles

Impact of microRNAs on cardiovascular diseases and aging.

Sheikh M, Salma U J Int Med Res. 2024; 52(10):3000605241279190.

PMID: 39370977 PMC: 11459564. DOI: 10.1177/03000605241279190.

Bioinformatics-based Analysis and Verification of Chromatin Regulators and the Mechanism of Immune Infiltration Associated with Myocardial Infarction.

Zhao H, Tang N, Xu L, Li J, Pi J, Chu Q Curr Med Chem. 2024; 32(1):188-209.

PMID: 39354722 DOI: 10.2174/0109298673265089231117054348.

Mechanism of KLF2 in young mice with pneumonia induced by Streptococcus pneumoniae.

Li X, Xu W, Jing T J Cardiothorac Surg. 2024; 19(1):509.

PMID: 39223627 PMC: 11367914. DOI: 10.1186/s13019-024-02995-2.

Is the Cis-Element CACCC-Box a Master Regulatory Element during Cardiovascular Disease? A Bioinformatics Approach from the Perspective of the Krüppel-like Family of Transcription Factors.

Garcia-Loredo J, Santoyo-Suarez M, Rodriguez-Nunez O, Benitez Chao D, Garza-Trevino E, Zapata-Morin P Life (Basel). 2024; 14(4).

PMID: 38672763 PMC: 11051458. DOI: 10.3390/life14040493.

Role of serum CAP1 protein in the diagnosis of patients with first-time acute myocardial infarction.

Jin D, Li X, Cong H, You B, Ma Y, Hu Y Medicine (Baltimore). 2023; 102(39):e34700.

PMID: 37773847 PMC: 10545083. DOI: 10.1097/MD.0000000000034700.

References

Hernandez-Resendiz S, Munoz-Vega M, Contreras W, Crespo-Avilan G, Rodriguez-Montesinos J, Arias-Carrion O . Responses of Endothelial Cells Towards Ischemic Conditioning Following Acute Myocardial Infarction. Cond Med. 2018; 1(5):247-258. PMC: 6191189. View

Finsterer J, Stollberger C, Krugluger W . Cardiac and noncardiac, particularly neuromuscular, disease with troponin-T positivity. Neth J Med. 2007; 65(8):289-95. View

Shen J, Xing W, Liu R, Zhang Y, Xie C, Gong F . MiR-32-5p influences high glucose-induced cardiac fibroblast proliferation and phenotypic alteration by inhibiting DUSP1. BMC Mol Biol. 2019; 20(1):21. PMC: 6704591. DOI: 10.1186/s12867-019-0135-x. View

Huang L, Li L, Chen X, Zhang H, Shi Z . MiR-103a targeting Piezo1 is involved in acute myocardial infarction through regulating endothelium function. Cardiol J. 2016; 23(5):556-562. DOI: 10.5603/CJ.a2016.0056. View

Liu J, Xiao X, Shen Y, Chen L, Xu C, Zhao H . MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. PLoS One. 2017; 12(3):e0174138. PMC: 5358880. DOI: 10.1371/journal.pone.0174138. View

Garikipati V, Verma S, Jolardarashi D, Cheng Z, Ibetti J, Cimini M . Therapeutic inhibition of miR-375 attenuates post-myocardial infarction inflammatory response and left ventricular dysfunction via PDK-1-AKT signalling axis. Cardiovasc Res. 2017; 113(8):938-949. PMC: 11008084. DOI: 10.1093/cvr/cvx052. View

Ong S, Hernandez-Resendiz S, Crespo-Avilan G, Mukhametshina R, Kwek X, Cabrera-Fuentes H . Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018; 186:73-87. PMC: 5981007. DOI: 10.1016/j.pharmthera.2018.01.001. View

Cao J, Chen L, Zhong X, Shen Y, Gao Y, Chen Q . miR32-5p promoted vascular smooth muscle cell calcification by upregulating TNFα in the microenvironment. BMC Immunol. 2020; 21(1):3. PMC: 6967090. DOI: 10.1186/s12865-019-0324-x. View

Yu J, Cao X, Zheng Y, Yan L, Wang J . Abnormal expression of miR‑133a in patients with acute myocardial infarction following radical surgery for gastric cancer and the underlying mechanism. Mol Med Rep. 2018; 18(6):5023-5029. PMC: 6236279. DOI: 10.3892/mmr.2018.9541. View

10.

Dekker R, van Soest S, Fontijn R, Salamanca S, de Groot P, VanBavel E . Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2). Blood. 2002; 100(5):1689-98. DOI: 10.1182/blood-2002-01-0046. View

11.

Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E . Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009; 361(9):868-77. DOI: 10.1056/NEJMoa0903515. View

12.

Bayoumi A, Teoh J, Aonuma T, Yuan Z, Ruan X, Tang Y . MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition. Cardiovasc Res. 2017; 113(13):1603-1614. PMC: 5852516. DOI: 10.1093/cvr/cvx132. View

13.

Liu H, Li G, Zhao W, Hu Y . Inhibition of MiR-92a May Protect Endothelial Cells After Acute Myocardial Infarction in Rats: Role of KLF2/4. Med Sci Monit. 2016; 22:2451-62. PMC: 4957625. DOI: 10.12659/msm.897266. View

14.

Zhang Z, Zhang A, Xu M, Lou J, Qiu W . TLR-4/miRNA-32-5p/FSTL1 signaling regulates mycobacterial survival and inflammatory responses in Mycobacterium tuberculosis-infected macrophages. Exp Cell Res. 2017; 352(2):313-321. DOI: 10.1016/j.yexcr.2017.02.025. View

15.

Jha P, Das H . KLF2 in Regulation of NF-κB-Mediated Immune Cell Function and Inflammation. Int J Mol Sci. 2017; 18(11). PMC: 5713352. DOI: 10.3390/ijms18112383. View

16.

Liu Y, Zhou H, Chen L, Qu D, Wang C, Xia Z . MiR-32-5p regulates the proliferation and metastasis of cervical cancer cells by targeting HOXB8. Eur Rev Med Pharmacol Sci. 2019; 23(1):87-95. DOI: 10.26355/eurrev_201901_16752. View

17.

Vacante F, Denby L, Sluimer J, Baker A . The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease. Vascul Pharmacol. 2018; 112:24-30. PMC: 6395947. DOI: 10.1016/j.vph.2018.11.006. View

18.

Xu Y, Xu S, Liu P, Koroleva M, Zhang S, Si S . Suberanilohydroxamic Acid as a Pharmacological Kruppel-Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis. J Am Heart Assoc. 2017; 6(12). PMC: 5779026. DOI: 10.1161/JAHA.117.007134. View

19.

Rakic M, Persic V, Kehler T, Bastiancic A, Rosovic I, Laskarin G . Possible role of circulating endothelial cells in patients after acute myocardial infarction. Med Hypotheses. 2018; 117:42-46. DOI: 10.1016/j.mehy.2018.06.005. View

20.

Ding S, Huang H, Xu Y, Zhu H, Zhong C . MiR-222 in Cardiovascular Diseases: Physiology and Pathology. Biomed Res Int. 2017; 2017:4962426. PMC: 5239839. DOI: 10.1155/2017/4962426. View